Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Primavera Essentials was a private U.S. consumer wellness company focused on THC-free cannabidiol (CBD) products rather than prescription biopharmaceutical development. The company marketed CBD tinctures, soft-gels, creams, salves, gummies, and a hemp-based topical product called Neuro-Eze for pain and wellness use cases. Its public messaging emphasized natural relief for aches and pains associated with aging, along with consumer education around CBD and hemp oil. Based on available records, it appears to have operated commercially as a direct-to-consumer CBD brand and is not a traditional biotech or pharma company with a clinical pipeline. Corporate registry evidence suggests the business is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Primavera Essentials.